Cell and Gene Therapy Catapult

Activities: Cell & Gene Therapy

Trending Articles

  1. SCIEX expands integrated software ecosystem with six mass spectrometry workflow collaborations The firm has announced six software collaborations designed to unify instrument control, data processing and compliance within a single analytical environment, with more...
  2. BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in...
  3. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with...
  4. Backed by investments exceeding $1 billion, PCI Pharma Services announces major expansion of US sterile fill-finish and drug-device delivery combination capabilities As pharma manufacturers prioritise US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and...
  5. SGS launches GMP-compliant NMR testing for Chinese pharma industry The inspection and certification specialist will now offer nuclear magnetic resonance (NMR) testing for analysis of both drug substances and drug products across China

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

Related Content

Finance

Horiba joins cell & gene therapy manufacturing consortium

Headed by the Cell and Gene Therapy Catapult, the consortium comprises technology providers, pharmaceutical companies, therapy developers and charities
Regulatory

NHC named National Training Centre for UK skills initiative

The National Horizons Centre will provide hands-on training for advanced therapy medicinal products (ATMPs) and vaccine manufacture
Finance

Stevenage cell and gene therapy facility receives £3m government grant

The cell and gene therapy cluster around Stevenage has reportedly been recognised as a high potential opportunity zone, set to attract overseas investment to the
Regulatory

CGT Catapult analyses manufacturing and skills in cell and gene therapy

New data has shown cell and gene therapy manufacturing facilities are rapidly becoming operational reflecting job expansion in the sector
Media

British cell and gene therapy accelerator releases annual report

The CGT Catapult has worked on more than 110 projects addressing industry challenges
Research & Development

CGT Catapult brings SMEs together

Fujifilm Diosynth, Eversheds Sutherland, Mathys & Squire and Stifel gather at CGT Catapult’s first UK Advanced Therapy Medicinal Products Investor Day
Research & Development

TCR2 Therapeutics and CGT Catapult join forces at UK Bioscience park

TCR<sup>2</sup> is the first US company to have a global development base at the Stevenage site, working with CGT Catapult to further its T cell therapies
Subscribe now